JPRN-UMIN000008842已完成未知
Multi-institutional randomized phase 2 trial of the combination chemotherapy of carboplatin and pemetrexed for advanced nonsquamous non-small-cell lung cancer - KCOG-T1112
Kansai Clinical Oncology Group0 个研究点目标入组 20 人开始时间: 2012年9月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Squamous cell carcinoma 2.Irradiation for praimary lesion 3.SVC syndrome 4.Uncontrollable pleural effusion 5.Massive ascites or pericardial efusion 6.Interstitial pneumonia revealed by chestXP 7.Symptomatic brain metastasis 8.Untreated double cancer
研究者
相似试验
招募中
2 期
Multi-institutional randomized Phase 2 trial of a treatment of nivolumab combined with stereotactic body radiotherapy for patients with unresectable or metastatic renal cell carcinoma.nresectable or metastatic renal cell carcinomaJPRN-UMIN000030972Department of Radiology, University of Yamanashi100
进行中（未招募）
不适用
A multicenter, randomised phase II trial on the therapy of advanced gastric cancer or adenocarcinoma of the esophagogastric junction in patients older than 65 years with special regard on quality of life and the pharmacogenetic risk profile - FLOT65+EUCTR2006-006936-24-DEKrankenhaus Nordwest GmbH108
招募中
2 期
IVOIGERCCnresectable or metastatic renal cell carcinomaJPRN-jRCTs031180024Onishi Hiroshi100
进行中（未招募）
1 期
A study to evaluate efficacy and safety of azazitidin alone or in combination with lenalidomide in patients with advanced cancer in the bone marrow or in the blood with a defective chromosome 5EUCTR2011-001639-21-SEMDSG Nordics Myeloplastics Syndrom Study Group72
进行中（未招募）
1 期
A study to evaluate efficacy and safety of azazitidin alone or in combination with lenalidomide in patients with advanced cancer in the bone marrow or in the blood with a defective chromosome 5EUCTR2011-001639-21-DKMDSG Nordics Myeloplastics Syndrom Study Group72